05:24 PM EST, 11/20/2025 (MT Newswires) -- Grey Wolf Animal Health (WOLF.V) on Thursday reported a 9.3% rise in third-quarter net income as higher revenue and stronger operating performance lifted results.

Net income for the period was $548,976, up from $502,151 a year earlier, and earnings per share held steady at $0.02. Operating income surged 54% year-on-year to $1.23 million in the three months period ended on Sept. 30

Revenue for the quarter climbed 35% year over year to $9.3 million, while adjusted EBITDA rose 62.3% to $1.9 million.

Growth was driven by both the Pharmacy and Animal Health businesses, said Angela Cechetto, Chief Executive Officer.

"Our Pharmacy business continues to perform well with sales up year-over-year by 52.4% to $5.8 million and 55.9% to $17.1 million respectively, in the quarter and year-to-date. This growth is driven by an increase in sales of compounded products and the impact of the acquisition of the Compounding Pharmacy of Manitoba (CPM) in December 2024."

The company's shares closed up $0.08 to $1.38 on the TSX Venture Exchange.